Inventor · disambiguated record
Tesfaye Biftu
Also filed as: BIFTU TESFAYE · ZUEGNER III LEGAL REPRESENTATI
84 granted patents·3 pending applications·877 citations·filing 1982–2025
99Inventor score
Top patents by PatentIndex Score
87 records- 0195US5780503ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Jul 14, 1998·76 cites·6 claims
- 0295US4595693AMethod of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonistsMERCK & CO INC·Filed 1984·Granted Jun 17, 1986·45 cites·3 claims
- 0394US9227973B2Pyridine CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·16 cites·4 claims
- 0494US5792776ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1994·Granted Aug 11, 1998·58 cites·30 claims
- 0591US8143289B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2009·Granted Mar 27, 2012·12 cites·25 claims
- 0691US4539332A2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonistsMERCK & CO INC·Filed 1983·Granted Sep 3, 1985·43 cites·9 claims
- 0790US11230543B2Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 0890US9296750B2Spirolactam CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 29, 2016·16 cites·3 claims
- 0990US9227972B2Aliphatic spirolactam CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·17 cites·4 claims
- 1089US9290517B2Azabenzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Mar 22, 2016·8 cites·20 claims
- 1189US8772328B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2013·Granted Jul 8, 2014·6 cites·2 claims
- 1289US7678905B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Mar 16, 2010·14 cites·20 claims
- 1389US4536512A5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agentsMERCK & CO INC·Filed 1982·Granted Aug 20, 1985·21 cites·7 claims
- 1488US9469608B2Thrombin inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 18, 2016·6 cites·20 claims
- 1588US8951965B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2014·Granted Feb 10, 2015·5 cites·2 claims
- 1688US8592371B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2013·Granted Nov 26, 2013·6 cites·1 claims
- 1788US6034106AOxadiazole benzenesulfonamides as selective β3 Agonist for the treatment of Diabetes and ObesityMERCK & CO INC·Filed 1997·Granted Mar 7, 2000·42 cites·4 claims
- 1887US9527839B2Benzimidazole tetrahydropyran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·6 cites·17 claims
- 1987US8980929B2Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetesHICKS JACQUELINE D·Filed 2011·Granted Mar 17, 2015·11 cites·15 claims
- 2087US8415297B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2012·Granted Apr 9, 2013·6 cites·5 claims
- 2187US5463083ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1994·Granted Oct 31, 1995·67 cites·27 claims
- 2287US5369125ACholesterol-lowering agentsMERCK & CO INC·Filed 1993·Granted Nov 29, 1994·42 cites·15 claims
- 2385US9932311B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Apr 3, 2018·4 cites·24 claims
- 2485US9382243B2Azabenzimidazole tetrahydropyran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jul 5, 2016·4 cites·10 claims
- 2584US11433055B2Chromane monobactam compounds for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2018·Granted Sep 6, 2022·2 cites·21 claims
- 2684US9403790B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2016·Granted Aug 2, 2016·2 cites·1 claims
- 2784US9278976B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetesMERCK SHARP & DOHME·Filed 2015·Granted Mar 8, 2016·2 cites·1 claims
- 2884US7750034B2Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Jul 6, 2010·8 cites·13 claims
- 2984US5741809ACompounds and methods for the treatment of cardiovascular inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Apr 21, 1998·55 cites·7 claims
- 3084US4511724A5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agentsMERCK & CO INC·Filed 1982·Granted Apr 16, 1985·15 cites·8 claims
- 3183US4757084A2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonistsMERCK & CO INC·Filed 1985·Granted Jul 12, 1988·32 cites·9 claims
- 3283US4533671A5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2-alkanoic or carboxylic acids and analogs as anti-inflammatory and analgesic agentsMERCK & CO INC·Filed 1982·Granted Aug 6, 1985·14 cites·7 claims
- 3382US5047420A1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonistsMERCK & CO INC·Filed 1989·Granted Sep 10, 1991·18 cites·8 claims
- 3481US9540364B2Benzimidazole tetrahydrofuran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 10, 2017·6 cites·18 claims
- 3579US8796258B2Cyclic azabenzimidazole derivatives useful as anti-diabetic agentsANAND RAJAN·Filed 2012·Granted Aug 5, 2014·6 cites·22 claims
- 3679US8653059B2Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2008·Granted Feb 18, 2014·4 cites·29 claims
- 3778US9868733B2Azabenzimidazole tetrahydrofuran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 16, 2018·4 cites·15 claims
- 3878US7482336B2Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2005·Granted Jan 27, 2009·3 cites·13 claims
- 3977US9556193B2Benzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·4 cites·16 claims
- 4077US9073930B2Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2013·Granted Jul 7, 2015·3 cites·15 claims
- 4176US7812027B2Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Oct 12, 2010·1 cites·13 claims
- 4274US9447085B2Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2013·Granted Sep 20, 2016·2 cites·10 claims
- 4374US5001123A2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonistsMERCK & CO INC·Filed 1989·Granted Mar 19, 1991·20 cites·9 claims
- 4474US4996203A2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonistsMERCK & CO INC·Filed 1989·Granted Feb 26, 1991·20 cites·17 claims
- 4573US12281114B2NK3 modulators and uses thereofKALLYOPE INC·Filed 2024·Granted Apr 22, 2025·0 cites·20 claims
- 4673US7196095B2(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compoundsMERCK & CO INC·Filed 2002·Granted Mar 27, 2007·8 cites·25 claims
- 4772US8853212B2Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetesWILKENING ROBERT R·Filed 2011·Granted Oct 7, 2014·4 cites·20 claims
- 4872US8455533B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2010·Granted Jun 4, 2013·2 cites·21 claims
- 4972US7101871B2Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2003·Granted Sep 5, 2006·6 cites·25 claims
- 5071US9340530B2Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted May 17, 2016·2 cites·14 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tesfaye Biftu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →